Integra LifeSciences IART Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.64B+0.6% | $1.64B-0.5% | $1.64B+1.3% | $1.62B-0.2% | $1.62B+0.9% | ||
| $790.34M-1.7% | $803.63M+2.6% | $783.14M+1.9% | $768.66M+1.9% | $754.65M+3.6% | ||
| $854.17M+2.7% | $831.62M-3.3% | $859.83M+0.8% | $853.07M-1.9% | $869.66M-1.4% | ||
| 51.9%+1.1pp | 50.9%-1.5pp | 52.3%-0.3pp | 52.6%-0.9pp | 53.5%-1.2pp | ||
| $97.74M-1.2% | $98.97M-6.1% | $105.39M-4.5% | $110.37M-2.4% | $113.14M-1.9% | ||
| $696.44M-0.5% | $699.7M-1.3% | $708.95M-1.1% | $717.1M-2.1% | $732.68M+2.2% | ||
| $2.11B-0.8% | $2.13B+0.2% | $2.12B+0.1% | $2.12B+31.4% | $1.62B+2.1% | ||
| -$489.44M+5.2% | -$516.41M-7.4% | -$480.78M+4.0% | -$500.69M-5,694% | $8.95M-68.5% | ||
| -29.8%+1.8pp | -31.6%-2.3pp | -29.3%+1.6pp | -30.9%-31.4pp | 0.6%-1.2pp | ||
| $89.91M+4.2% | $86.26M+5.7% | $81.57M+4.3% | $78.21M+3.2% | $75.82M+7.3% | ||
| $18.16M-1.7% | $18.47M-2.8% | $19.01M-0.4% | $19.07M-1.8% | $19.42M-3.1% | ||
| —— | —— | -$1.93M-288% | $1.03M-76.7% | $4.41M+11.8% | ||
| -$540.19M+4.9% | -$567.81M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$495.8M+4.0% | -$516.47M— | —— | —— | —— | ||
| -30.1%+1.4pp | -31.6%— | —— | —— | —— | ||
| -$6.46+4.0% | -$6.73— | —— | —— | —— | ||
| -$6.46+4.0% | -$6.73— | —— | —— | —— | ||
| 307.1M+0.2% | 306.6M-0.1% | 306.9M+0.1% | 306.6M-0.2% | 307.3M-0.4% | ||
| 307.1M+0.2% | 306.6M-0.1% | 306.9M+0.1% | 306.6M-0.2% | 307.3M-0.4% | ||
| $15.03M+0.5% | $14.95M+0.4% | $14.9M-0.2% | $14.93M+0.3% | $14.89M-30.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | -$1.93M-288% | $1.03M-76.7% | $4.41M+11.8% | ||
| $97.74M-1.2% | $98.97M-6.1% | $105.39M-4.5% | $110.37M-2.4% | $113.14M-1.9% | ||
| $1.64B+0.6% | $1.64B-0.5% | $1.64B+1.3% | $1.62B-0.2% | $1.62B+0.9% | ||
| -$489.44M+5.2% | -$516.41M-7.4% | -$480.78M+4.0% | -$500.69M-5,694% | $8.95M-68.5% | ||
| -$321.34M+8.1% | -$349.62M-11.0% | -$314.89M+6.7% | -$337.33M-297% | $171.35M-10.1% | ||
| -$321.34M+8.1% | -$349.62M-11.0% | -$314.89M+6.7% | -$337.33M-297% | $171.35M-10.1% | ||
| -19.5%+1.8pp | -21.4%-2.2pp | -19.2%+1.6pp | -20.8%-31.3pp | 10.5%-1.3pp | ||
| -$489.44M+5.2% | -$516.41M-7.4% | -$480.78M+4.0% | -$500.69M-5,694% | $8.95M-68.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Integra LifeSciences's revenue?
- Integra LifeSciences (IART) generated $1.6B in revenue over the trailing twelve months, up 1.2% year over year.
- Is Integra LifeSciences profitable?
- Integra LifeSciences is not currently profitable: it reported a net loss of $495.8M over the trailing twelve months, a -30.1% net margin.
- What are Integra LifeSciences's profit margins?
- Gross margin is 51.9% and operating margin is -29.8%, with a -30.1% net margin.
- What is Integra LifeSciences's earnings per share?
- Integra LifeSciences's diluted EPS over the trailing twelve months is $-6.46.
- Where does Integra LifeSciences's income statement data come from?
- Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
